CANCER ADVANCES

cancer-advances-logo

Cancer Advances is a biotechnology company focused on impacting human health and the progression of gastrointestinal cancers by enhancing the adaptive immune system. The company is led by an experienced management team and has a broad intellectual property portfolio. Cancer Advances is a wholly owned subsidiary of Cato BioVentures. The company's lead compound, Polyclonal Antibody Stimulator (PAS), is an immunomodulator used to treat gastrointestinal cancer. Please visit their Product page for more information on what is in development.

#People #Website #More

CANCER ADVANCES

Industry:
Biotechnology

Address:
Durham, North Carolina, United States

Country:
United States

Website Url:
http://www.canceradvancesinc.com

Status:
Closed

Contact:
919-361-2286

Email Addresses:
[email protected]

Technology used in webpage:
Microsoft Exchange Online Google Maps Amazon Route 53 Network Solutions


Current Employees Featured

lynda-sutton_image

Lynda Sutton
Lynda Sutton President @ Cancer Advances
President
2008-06-01

Official Site Inspections

http://www.canceradvancesinc.com

Unable to get host informations!!!

Loading ...

More informations about "Cancer Advances"

About - Cancer Advances

About Cancer Advances, Inc., is a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers and other cancers. The company is focused on โ€ฆ See details»

Cancer Advances - Crunchbase Company Profile

Cancer Advances is a biotechnology company focused on impacting human health and the progression of gastrointestinal cancers by enhancing the โ€ฆ See details»

Cancer Advances 2025 Company Profile: Valuation, โ€ฆ

Information on valuation, funding, cap tables, investors, and executives for Cancer Advances. Use the PitchBook Platform to explore the full profile. See details»

Cancer Advances, Inc. - LinkedIn

Cancer Advances, Inc. Biotechnology Research Durham, North Carolina 100 followers Cancer Advances is dedicated to pioneering new medicines and redefining possibilities for cancer โ€ฆ See details»

Cancer Advances Inc · 4364 S Alston Ave, Durham, NC 27713-2220 โ€ฆ

CANCER ADVANCES INC is an entity in Durham, North Carolina registered with the System for Award Management (SAM) of U.S. General Services Administration (GSA). The entity was โ€ฆ See details»

Cancer Advances, Inc. - Drug pipelines, Patents, Clinical trials

Cancer Advances plans to seek approval for PAS in the treatment of gastric and pancreatic cancers. About Cancer Advances, Inc. Cancer Advances Inc. (Durham, NC) is a biotechnology โ€ฆ See details»

Cancer Advances Company Profile - Office Locations, Competitors โ€ฆ

Cancer Advances has 5 employees at their 1 location. See insights on Cancer Advances including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. See details»

Cancer Advances Inc. - VentureRadar

Cancer Advances, a subsidiary of Cato Bioventures, develops immunomodulator therapeutics to treat gastrointestinal cancers. ... Find out more about Cancer Advances Inc., Therapeutics, โ€ฆ See details»

Contact | Cancer Advances

Westpark Corporate Center 4364 South Alston Avenue Suite 105 Durham, North Carolina USA 27713 See details»

Cancer Advances, Inc. - Phone, Email, Employees, CEO, VP, 2022

Cancer Advances, Inc. (https://www.canceradvancesinc.com) location in North Carolina, United States , revenue, industry and description. Find related and similar companies as well as โ€ฆ See details»

Cancer Advances Acquires the Intellectual Property for a Suite of ...

DURHAM, N.C., Feb. 2 /PRNewswire/ -- Cancer Advances, Inc. (Cancer Advances), a Cato BioVentures portfolio company, announced today that it has completed its acquisition of all the โ€ฆ See details»

Cancer Advances Inc. :: North Carolina (US) :: OpenCorporates

Free and open company data on North Carolina (US) company Cancer Advances Inc. (company number 1045342), 2626 Glenwood Avenue,, Suite 550, Raleigh, NC, 27608 See details»

Cancer Advances, Inc. - Company Profile & Staff Directory

Cancer Advances, Inc. is a Biotechnology company located in Durham US with 2 employees. Access Cancer Advances, Inc.'s email format and Cancer Advances, Inc. staff directory for โ€ฆ See details»

News & Events - Cancer Advances

DURHAM, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) โ€” Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal (GI) cancers, โ€ฆ See details»

Cancer Advances, Inc. Announces Abstract at AACR

Mar 23, 2021 Cancer Advances Inc. (Durham, NC) is a biotechnology company focused on impacting human health and preventing the progression of gastrointestinal cancers by โ€ฆ See details»

Cancer Advances

Cancer Advances is focused on developing therapeutics for gastrin/ gastrin receptor (CCKB) producing tumors. The companyโ€™s lead product, Polyclonal Antibody Stimulator (PAS), is an โ€ฆ See details»

Press Releases | Cancer Advances

Dec 6, 2021 Apr 7, 2021 | Press Releases Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, announces โ€ฆ See details»

Cancer Advances, Inc. Announces Issuance of New U.S. Patent

DURHAM, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) โ€” Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal (GI) cancers, โ€ฆ See details»

Cancer Advances-Hill Publishing Group

Nov 18, 2024 Cancer Advances-Hill Publishing GroupAbout this Journal Cancer Advances publishes regular papers and special issues on specific topics of interest to international โ€ฆ See details»

Our Science - Cancer Advances

The incidence of pancreatic cancer is increasing signi๏ฌ-cantly and will soon become the second leading cause of cancer-related deaths in the United States. We have previ-ously shown that โ€ฆ See details»